Cargando…
SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
Disclosure: C. Wiepjes: Advisory Board Member; Self; Novartis Pharmaceuticals. M. Den Heijer: None. Background Autoimmune diseases are more common in women than in men, possibly caused by differences in sex hormones. Generally, estrogen has an immunoenhancing effect, while testosterone has an immuno...
Autores principales: | Wiepjes, Chantal, Heijer, Martin Den |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554423/ http://dx.doi.org/10.1210/jendso/bvad114.2087 |
Ejemplares similares
-
SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023) -
OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023) -
SAT645 Cardiac Autonomic Modulation In Transgender Men Under Gender-affirming Hormone Therapy
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2023) -
SAT410 Echocardiogram Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: Mobilia Alvares, Leonardo Azevedo, et al.
Publicado: (2023) -
SAT405 Bone Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: dos Santos, Lívia Marcela, et al.
Publicado: (2023)